Traws Pharma Stock (NASDAQ: TRAW) stock price, news, charts, stock research, profile.
Open | $0.40 |
Close | $0.38 |
Volume / Avg. | 80.63K / 113.20K |
Day Range | 0.37 - 0.40 |
52 Wk Range | 0.36 - 0.99 |
Market Cap | $9.82M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 0.11% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Traws Pharma (NASDAQ:TRAW) through any online brokerage.
Other companies in Traws Pharma’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Akanda (NASDAQ:AKAN).
There is no analysis for Traws Pharma.
There is no analysis for Traws Pharma to provide a consensus price target.
The stock price for Traws Pharma (NASDAQ: TRAW) is $0.3883 last updated July 5, 2024 at 5:05 PM EDT.
There are no upcoming dividends for Traws Pharma.
Traws Pharma’s Q2 earnings are confirmed for Friday, August 16, 2024.
There is no upcoming split for Traws Pharma.
Traws Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.